Molecular Imaging Research Center, Korea Institute of Radiological and Medical Sciences-KIRAMS, Seoul, Republic of Korea.
Cancer Biother Radiopharm. 2012 Dec;27(10):719-28. doi: 10.1089/cbr.2012.1225. Epub 2012 Sep 25.
Cell-tracking methods with molecular-imaging modality can monitor the biodistribution of cells. In this study, the direct-labeling method with ⁶⁴Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (⁶⁴Cu-PTSM), indirect cell-labeling methods with herpes simplex virus type 1-thymidine kinase (HSV1-tk)-mediated ¹²⁴I-2'-fluoro-2'-deoxy-1-β-D-arabinofuranosyl-5-iodouracil (¹²⁴I-FIAU) were comparatively investigated in vitro and in vivo for tracking of human chronic myelogenous leukemia cells. K562-TL was established by retroviral transduction of the HSV1-tk and firefly luciferase gene in the K562 cell. K562-TL cells were labeled with ⁶⁴Cu-PTSM or ¹²⁴I-FIAU. Cell labeling efficiency, viability, and radiolabels retention were compared in vitro. The biodistribution of radiolabeled K562-TL cells with each radiolabel and small-animal positron emission tomography imaging were performed. Additionally, in vivo and ex vivo bioluminescence imaging (BLI) and tissue reverse transcriptase-polymerase chain reaction (RT-PCR) analysis were used for confirming those results. K562-TL cells were efficiently labeled with both radiolabels. The radiolabel retention (%) of ¹²⁴I-FIAU (95.2%±1.1%) was fourfold higher than ⁶⁴Cu-PTSM (23.6%±0.7%) at 24 hours postlabeling. Viability of radiolabeled cells was statistically nonsignificant between ¹²⁴I-FIAU and ⁶⁴Cu-PTSM. The radioactivity of each radiolabeled cells was predominantly accumulated in the lungs and liver at 2 hours. Both the radioactivity of ⁶⁴Cu-PTSM- and ¹²⁴I-FIAU-labeled cells was highly accumulated in the liver at 24 hours. However, the radioactivity of ¹²⁴I-FIAU-labeled cells was markedly decreased from the body at 24 hours. The K562-TL cells were dominantly localized in the lungs and liver, which also verified by BLI and RT-PCR analysis at 2 and 24 hours postinjection. The ⁶⁴Cu-PTSM-labeled cell-tracking method is more efficient than ¹²⁴I-FIAU-labeled cell tracking, because of markedly decrease of radioactivity and fast efflux of ¹²⁴I-FIAU in vivo. In spite of a high labeling yield and radiolabel retention of ¹²⁴I-FIAU in vitro, the in vivo cell-tracking method using ⁶⁴Cu-PTSM could be a useful method to evaluate the distribution and targeting of various cell types, especially, stem cells and immune cells.
细胞示踪方法与分子成像方式可监测细胞的生物分布。在这项研究中,比较了直接标记法(⁶⁴Cu-丙酮酸双(N4-甲基硫代半卡巴腙)(⁶⁴Cu-PTSM))和间接细胞标记法(单纯疱疹病毒 1-胸苷激酶(HSV1-tk)介导的¹²⁴I-2'-氟-2'-脱氧-1-β-D-阿拉伯呋喃糖基-5-碘尿嘧啶(¹²⁴I-FIAU))在体外和体内用于追踪人慢性髓系白血病细胞。通过逆转录病毒转导将 HSV1-tk 和萤火虫荧光素酶基因转入 K562 细胞中,建立 K562-TL 细胞。用⁶⁴Cu-PTSM 或¹²⁴I-FIAU 标记 K562-TL 细胞。比较了细胞标记效率、活力和放射性标记物保留率。进行了放射性标记的 K562-TL 细胞的每种放射性标记物的生物分布和小动物正电子发射断层扫描成像。此外,还进行了体内和体外生物发光成像(BLI)和组织逆转录酶-聚合酶链反应(RT-PCR)分析,以确认这些结果。两种放射性标记物均能有效地标记 K562-TL 细胞。¹²⁴I-FIAU 的放射性标记物保留率(95.2%±1.1%)在 24 小时标记后是⁶⁴Cu-PTSM(23.6%±0.7%)的四倍。¹²⁴I-FIAU 和⁶⁴Cu-PTSM 之间的放射性标记细胞活力无统计学差异。两种放射性标记细胞的放射性在 2 小时时主要积聚在肺和肝脏中。在 24 小时时,两种放射性标记物的放射性均高度积聚在肝脏中。然而,在 24 小时时,¹²⁴I-FIAU 标记细胞的放射性从体内明显减少。K562-TL 细胞主要定位于肺和肝脏,在注射后 2 和 24 小时的 BLI 和 RT-PCR 分析中也得到了证实。由于¹²⁴I-FIAU 在体内的放射性迅速减少和快速流出,⁶⁴Cu-PTSM 标记的细胞示踪方法比¹²⁴I-FIAU 标记的细胞跟踪更有效。尽管 ¹²⁴I-FIAU 在体外具有高标记产率和放射性标记物保留率,但使用⁶⁴Cu-PTSM 的体内细胞示踪方法可用于评估各种细胞类型(尤其是干细胞和免疫细胞)的分布和靶向性。